Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

1.1K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

132
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
132
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.7K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

1.1K
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
1.1K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

1.6K
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.6K
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

5.9K
Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-Acquired Pneumonia in Nursing-Home Residents in the Post-HCAP Era.

Chest·2026
Same author

Complement Anaphylatoxin C5a-Induced Mouse Lymphatic Functions Modulate Interactions Between Endothelial Cells and T Lymphocytes.

Immune network·2026
Same author

HSR26-201: Prognostic Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Semaglutide as a potential tool in pre-lung transplant weight loss optimization.

JCEM case reports·2026
Same author

HSR26-201: Implications of Interleukin-6 Levels in Hospitalized Patients With COVID-19: Impact of Cancer Status on Mortality.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Balance Versus Bias: Correcting Misinformation About the 2025 ATS Community-Acquired Pneumonia Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: Apr 10, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

8.1K

Aerosolized Antibiotics.

Marcos I Restrepo1, Holly Keyt2, Luis F Reyes3

  • 1University of Texas Health Science Center at San Antonio, San Antonio, Texas. South Texas Veterans Health Care System, San Antonio, Texas. restrepom@uthscsa.edu.

Respiratory Care
|June 14, 2015
PubMed
Summary
This summary is machine-generated.

Aerosolized antibiotics offer targeted treatment for airway diseases like cystic fibrosis (CF), non-CF bronchiectasis (NCFB), and ventilator-associated pneumonia (VAP), potentially reducing side effects. Evidence supports their use, particularly in CF, with growing interest for NCFB and VAP.

Keywords:
aerosolsantibacterial agentsbronchiectasiscystic fibrosis (CF)ventilator-associated pneumonia (VAP)

More Related Videos

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.8K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.6K

Related Experiment Videos

Last Updated: Apr 10, 2026

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

8.1K
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.8K
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
04:59

Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models

Published on: August 18, 2023

1.6K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Aerosol medication delivery targets airways directly, maximizing drug concentration.
  • This method aims to reduce systemic absorption and adverse effects compared to conventional routes.
  • Bacterial infections in cystic fibrosis (CF), non-CF bronchiectasis (NCFB), and ventilator-associated pneumonia (VAP) are significant clinical challenges.

Purpose of the Study:

  • To review the evidence supporting aerosolized antibiotic use for airway infections.
  • To discuss clinical considerations for prescribing aerosolized antibiotics in CF, NCFB, and VAP.
  • To evaluate the potential of aerosolized antibiotics in NCFB and VAP, drawing parallels with CF successes.

Main Methods:

  • Systematic review of existing literature on aerosolized antibiotic therapy.
  • Analysis of clinical trial data and case studies.
  • Synthesis of evidence regarding efficacy and safety profiles.

Main Results:

  • Aerosolized antibiotics are most established and successful in treating CF lung infections.
  • Evidence for NCFB and VAP is emerging, suggesting potential benefits.
  • High local drug concentrations are achievable, with generally lower systemic exposure.

Conclusions:

  • Aerosolized antibiotics represent a promising therapeutic strategy for various airway bacterial infections.
  • Further research is warranted to optimize use in NCFB and VAP.
  • Clinicians require specific guidance for effective and safe prescription in these patient populations.